Abstract
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disorder associated with increased risk for thrombosis and reduced life expectancy. Retinal vein occlusion (RVO) is a frequent cause of vision loss but its relationship with PNH has not been studied systematically. Patients followed up for RVO in our ophthalmology department were screened for the presence of a PNH clone in peripheral blood by means of flow cytometry. The presence of other well-documented risk factors for RVO was also analyzed. In a series of 110 patients (54 males, median age of 67) we found no evidence of PNH. Most patients (97/110) had cardiovascular risk factors and/or hyperhomocysteinemia (67/110). Inherited thrombophilias were rare (three confirmed cases). Therefore, PNH does not appear to play a role in the development of RVO. However, this finding does not necessarily apply to young patients and/or those with no conventional risk factors for RVO, due to the low number of patients in these subgroups in our population.
References
Brodsky RA (2014) Paroxysmal nocturnal hemoglobinuria. Blood 124:2804–2811. doi:10.1182/blood-2014-02-522128
Takeda J, Miyata T, Kawagoe K, Iida Y, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703–711
Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, Khursigara G, Bedrosian C, Hillmen P (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99:922–929. doi:10.3324/haematol.2013.093161
de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Socié G, French Society of Hematology (2008) Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099–3106. doi:10.1182/blood-2008-01-133918
Preis M, Lowrey CH (2014) Laboratory tests for paroxysmal nocturnal hemoglobinuria. Am J Hematol 89:339–341. doi:10.1002/ajh.23612
Martí-Carvajal AJ, Anand V, Cardona AF, Solà I (2014) Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria. Cochrane Database Syst Rev 10:CD010340. doi:10.1002/14651858.CD010340
Jaulim A, Ahmed B, Khanam T, Chatziralli IP (2013) Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina 33:901–910. doi:10.1097/IAE.0b013e3182870c15
Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98:133–141
Rehak J, Rehak M (2008) Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res 33:111–131. doi:10.1080/02713680701851902
Stem MS, Talwar N, Comer GM, Stein JD (2013) A longitudinal analysis of risk factors associated with central retinal vein occlusion. Ophthalmology 120:362–370. doi:10.1016/j.ophtha.2012.07.080
Newman-Casey PA, Stem M, Talwar N, Musch DC, Besirli CG, Stein JD (2014) Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology 121:1939–1948. doi:10.1016/j.ophtha.2014.04.045
Minniti G, Calevo MG, Giannattasio A, Camicione P, Armani U, Lorini R, Piana G (2014) Plasma homocysteine in patients with retinal vein occlusion. Eur J Ophthalmol 24:735–743. doi:10.5301/ejo.5000426
Kolar P. (2014) Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. doi:10.1155/2014/724780
Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ (2005) Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 93:1021–1026. doi:10.1160/TH04-11-0768
Ziakas PD, Poulou LS, Rokas GI, Bartzoudis D, Voulgarelis M (2007) Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 5:642–645. doi:10.1111/j.1538-7836.2007.02379.x
Sutherland DR, Kuek N, Davidson J, Barth D, Chang H, Yeo E, Bamford S, Chin-Yee I, Keeney M (2007) Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B 72:167–177. doi:10.1002/cyto.b.20151
Cugati S, Wang JJ, Rochtchina E, Mitchell P (2006) Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 124:726–732. doi:10.1001/archopht.124.5.726
Adamczuk YP, Iglesias Varela ML, Martinuzzo ME, Martinuzzo ME, Cerrato GS, Forastiero RR (2002) Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 13:623–626
Schockman S, Glueck CJ, Hutchins RK, Patel J, Shah P, Wang P (2015) Diagnostic ramifications of ocular vascular occlusion as a first thrombotic event associated with factor V Leiden and prothrombin gene heterozygosity. Clin Ophthalmol 9:591–600. doi:10.2147/OPTH.S80714
Napal JJ, Neila S, Pérez-Montes R, Sierra I, Ruiz S, Hernández JL (2016) The role of coagulation disorders in patients with retinal vein occlusion. QJM 109:97–102. doi:10.1093/qjmed/hcv088
Kirkegaard K, Heegaard S, Hvas AM (2017) No evidence for thrombophilia in patients with retinal venous occlusion: a systematic GRADE-based review. Acta Ophthalmol 95:12–19. doi:10.1111/aos.13214
Glueck CJ, Hutchins RK, Jurantee J, Khan Z, Wang P (2012) Thrombophilia and retinal vascular occlusion. Clin Ophthalmol 6:1377–1384. doi:10.2147/OPTH.S34627
Scheuerle AF, Serbecic N, Beutelspacher SC (2009) Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions. Int Ophthalmol 29:187–190. doi:10.1007/s10792-007-9188-9
Ageno W, Dentali F, De Stefano V, Barco S, Lerede T, Bazzan M, Piana A, Santoro R, Duce R, Poli D, Martinelli I, Siragusa S, Barillari G, Cattaneo M, Vidili G, Carpenedo M, Rancan E, Giaretta I, Tosetto A (2014) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. Thromb Res 133:1052–1055. doi:10.1016/j.thromres.2014.03.044
Donadini MP, Dentali F, Ageno W (2012) Splanchnic vein thrombosis: new risk factors and management. Thromb Res 129(Suppl 1):S93–S96. doi:10.1016/S0049-3848(12)70025-7
Rehak M, Krcova V, Slavik L, Fric E, Langova K, Ulehlova J, Rehak J (2010) The role of thrombophilia in patients with retinal vein occlusion and no systemic risk factors. Can J Ophthalmol 45:171–175. doi:10.3129/i09-273
Yau JW, Lee P, Wong TY, Best J, Jenkins A (2008) Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J 38:904–910. doi:10.1111/j.1445-5994.2008.01720.x
Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 96:5209–5214. doi:10.1182/blood-2004-04-1472
Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA (2005) PIG-A mutations in normal hematopoiesis. Blood 105:3848–3854
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Alexion Barcelona provided FLAER.
Rights and permissions
About this article
Cite this article
Sorigue, M., Juncà, J., Orna, E. et al. Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria. J Thromb Thrombolysis 44, 63–66 (2017). https://doi.org/10.1007/s11239-017-1502-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-017-1502-4